Stock Price Quote

JHS SVENDGAARD LABORATORIES LTD.

NSE : JHSBSE : 532771ISIN CODE : INE544H01014Industry : Household & Personal ProductsHouse : Private
BSE12.35-0.19 (-1.52 %)
PREV CLOSE ( ) 12.54
OPEN PRICE ( ) 12.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 37070
TODAY'S LOW / HIGH ( )12.20 13.02
52 WK LOW / HIGH ( )11.68 32.9
NSE12.19-0.25 (-2.01 %)
PREV CLOSE( ) 12.44
OPEN PRICE ( ) 12.94
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 327233
TODAY'S LOW / HIGH( ) 12.10 12.94
52 WK LOW / HIGH ( )11.5 32.69
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 2004
Management Info
Rajagopal Chakravarthi Venkateish - Chairman Nikhil Nanda - Managing Director
Registered Office

Address Trilokpur Road,Kheri (Kala- Amb),Tehsil- Nahan,
Sirmour Dist,
Himachal Pradesh-173030

Phone 01702-302119 / 121 / 102 / 9218400346

Email enquiry@svendgaard.com

Website www.svendgaard.com

Registrars Details
Alankit Assignments Ltd.
3 E,7, Jhandewalan Extension,,New Delhi
Listing : BSE, NSE

NEWS

05Mar JHS Svendgaard Laboratories informs ab
In terms of the provisions of Regulation 30 of SEBI (Listing Obligations..
05Mar JHS Svendgaard Laboratories gets nod f
JHS Svendgaard Laboratories has received approval from board of director..
19Sep Jhs Svendgaard Laboratories informs ab
Jhs Svendgaard Laboratories has informed that JHS Svendgaard Laboratorie..
19Aug Jhs Svendgaard Laboratories informs ab
Jhs Svendgaard Laboratories has informed that it enclosed Newspaper publ..
17Aug JHS Svendgaard Laboratories informs ab
In terms of Regulation 30 and 33 of SEBI (Listing Obligations and Disclo..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit-18.36-40.49
Gross Profit -15.82 -34.2
Operating Profit 5.2200000000000333.86
Net Sales 226.6707.98

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Galaxy Surfactants (BSE)
peergroup  2139.30 (1.31%)
M.Cap ( in Cr)7584.84
Pee Cee Cosma Sope (BSE)
peergroup  592.25 (4.39%)
M.Cap ( in Cr)156.72
P&G Hygiene (BSE)
peergroup  13534.25 (0.15%)
M.Cap ( in Cr)43933.17
Sheela Foam (BSE)
peergroup  714.80 (2.55%)
M.Cap ( in Cr)7770.30
AARTISURF (BSE)
peergroup  446.20 (2.86%)
M.Cap ( in Cr)377.42

Shareholding Pattern

NON-INSTITUTION 63.85%
PROMOTERS 34.56%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About JHS Svendgaard Laboratories Ltd.

JHS Svendgaard Laboratories Ltd. was incorporated in the year 2004. Its today's share price is 12.35. Its current market capitalisation stands at Rs 105.72 Cr. In the latest quarter, company has reported Gross Sales of Rs. 707.98 Cr and Total Income of Rs.751.13 Cr. The company's management includes Vinay Mittal, Kapil Minocha, Upma Chawdhry, Mukul Pathak, Nikhil Nanda, Rajagopal Chakravarthi Venkateish, Komal Jha.

It is listed on the BSE with a BSE Code of 532771 , NSE with an NSE Symbol of JHS and ISIN of INE544H01014. It's Registered office is at Trilokpur Road,Kheri (Kala- Amb),Tehsil- NahanSirmour Dist-173030, Himachal Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Haribhakti & Co, SN Dhawan & Co, SN Dhawan & Co LLP, Tattvam & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.